fenil210/Med-Lamma huggingface dataset:
What are the symptoms of Juvenile Myelomonocytic Leukemia ?
Signs and symptoms of juvenile myelomonocytic leukemia include fever, weight loss, and feeling very tired. These and other signs and symptoms may be caused by JMML or by other conditions. Check with your doctor if you have any of the following:         -  Fever for no known reason.    - Having infections, such as bronchitis or tonsillitis.    - Feeling very tired.    - Easy bruising or bleeding.    - Skin rash.    - Painless swelling of the lymph nodes in the neck, underarm, stomach, or groin.    - Pain or a feeling of fullness below the ribs. + CancerGov + Juvenile Myelomonocytic Leukemia
What is the outlook for Juvenile Myelomonocytic Leukemia ?
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options for JMML depend on the following:         - The age of the child at diagnosis.    - The number of platelets in the blood.    - The amount of a certain type of hemoglobin in red blood cells. + CancerGov + Juvenile Myelomonocytic Leukemia
What are the treatments for Juvenile Myelomonocytic Leukemia ?
Treatment of juvenile myelomonocytic leukemia (JMML) may include the following:         -  Combination chemotherapy.    -  Stem cell transplant.    -  13-cis-retinoic acid therapy.    - A clinical trial of a new treatment, such as targeted therapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with juvenile myelomonocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website. + CancerGov + Juvenile Myelomonocytic Leukemia
How to diagnose Childhood Vascular Tumors ?
Tests are used to detect (find) and diagnose childhood vascular tumors. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps, lesions, or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.     -   Ultrasound exam: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. The picture can be printed to be looked at later.    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.    -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).     -   Biopsy : The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. A biopsy is not always needed to diagnose a vascular tumor. + CancerGov + Childhood Vascular Tumors
what research (or clinical trials) is being done for Childhood Vascular Tumors ?
New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the research process. Clinical trials are done to find out if new treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way disease will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose tumors have not gotten better. There are also clinical trials that test new ways to stop tumors from recurring (coming back) or reduce the side effects of treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials. + CancerGov + Childhood Vascular Tumors
What causes Childhood Brain Stem Glioma ?
The cause of most childhood brain tumors is unknown. + CancerGov + Childhood Brain Stem Glioma
Who is at risk for Childhood Brain Stem Glioma? ?
Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your child's doctor if you think your child may be at risk. Possible risk factors for brain stem glioma include:          - Having certain genetic disorders, such as neurofibromatosis type 1 (NF1). + CancerGov + Childhood Brain Stem Glioma
What are the symptoms of Childhood Brain Stem Glioma ?
The signs and symptoms of brain stem glioma are not the same in every child. Signs and symptoms depend on the following:          - Where the tumor forms in the brain.    - The size of the tumor and whether it has spread all through the brain stem.    - How fast the tumor grows.    - The child's age and development.        Some tumors do not cause signs or symptoms. Signs and symptoms may be caused by childhood brain stem gliomas or by other conditions. Check with your child's doctor if your child has any of the following:         - Loss of ability to move one side of the face and/or body.    - Loss of balance and trouble walking.     - Vision and hearing problems.    - Morning headache or headache that goes away after vomiting.    -  Nausea and vomiting.    - Unusual sleepiness.    - More or less energy than usual.    - Changes in behavior.    - Trouble learning in school. + CancerGov + Childhood Brain Stem Glioma
How to diagnose Childhood Brain Stem Glioma ?
Tests that examine the brain are used to detect (find) childhood brain stem glioma. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -   Neurological exam : A series of questions and tests to check the brain, spinal cord, and nerve function. The exam checks a persons mental status, coordination, and ability to walk normally, and how well the muscles, senses, and reflexes work. This may also be called a neuro exam or a neurologic exam.     -   MRI (magnetic resonance imaging) with gadolinium : A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the brain. A substance called gadolinium is injected into a vein. The gadolinium collects around the cancer cells so they show up brighter in the picture. This procedure is also called nuclear magnetic resonance imaging (NMRI).
                    - A biopsy may be done to diagnose certain types of brain stem glioma. If the MRI scan looks like the tumor is a DIPG, a biopsy is usually not done and the tumor is not removed.    If the MRI scan looks like a focal brain stem glioma, a biopsy may be done. A part of the skull is removed and a needle is used to remove a sample of the brain tissue. Sometimes, the needle is guided by a computer. A pathologist views the tissue under a microscope to look for cancer cells. If cancer cells are found, the doctor will remove as much tumor as safely possible during the same surgery.    The following test may be done on the tissue that was removed:         -   Immunohistochemistry : A test that uses antibodies to check for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the tissue to light up under a microscope. This type of test may be used to tell the difference between brain stem glioma and other brain tumors. + CancerGov + Childhood Brain Stem Glioma
What is the outlook for Childhood Brain Stem Glioma ?
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis and treatment options depend on:         - The type of brain stem glioma.    - Where the tumor is found in the brain and if it has spread within the brain stem.    - The age of the child when diagnosed.    - Whether or not the child has a condition called neurofibromatosis type 1.    - Whether the tumor has just been diagnosed or has recurred (come back). + CancerGov + Childhood Brain Stem Glioma
What are the stages of Childhood Brain Stem Glioma ?
Key Points
                    - The plan for cancer treatment depends on whether the tumor is in one area of the brain or has spread all through the brain.
                
                
                    The plan for cancer treatment depends on whether the tumor is in one area of the brain or has spread all through the brain.
                    Staging is the process used to find out how much cancer there is and if cancer has spread. It is important to know the stage in order to plan treatment.    There is no standard staging system for childhood brain stem glioma. Treatment is based on the following:         - Whether the tumor is newly diagnosed or recurrent (has come back after treatment).    - The type of tumor (either a diffuse intrinsic pontine glioma or a focal glioma). + CancerGov + Childhood Brain Stem Glioma
what research (or clinical trials) is being done for Childhood Brain Stem Glioma ?
New types of treatment are being tested in clinical trials.
                 Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials. + CancerGov + Childhood Brain Stem Glioma
What is (are) Colorectal Cancer ?
Key Points
                    - Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum.     - Colorectal cancer is the second leading cause of death from cancer in the United States.     - Different factors increase or decrease the risk of getting colorectal cancer.
                
                
                    Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum.
                    The colon and rectum are parts of the body's digestive system. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The digestive system is made up of the mouth, throat, esophagus, stomach, and the small and large intestines. The colon (large bowel) is the first part of the large intestine and is about 5 feet long. Together, the rectum and anal canal make up the last part of the large intestine and are 6-8 inches long. The anal canal ends at the anus (the opening of the large intestine to the outside of the body).      Cancer that begins in the colon is called colon cancer, and cancer that begins in the rectum is called rectal cancer. Cancer that begins in either of these organs may also be called colorectal cancer.   See the following PDQ summaries for more information about colorectal cancer:         -   Colorectal Cancer Prevention     -  Colon Cancer Treatment     -  Rectal Cancer Treatment     -  Genetics of Colorectal Cancer
                
                
                    Colorectal cancer is the second leading cause of death from cancer in the United States.
                    The number of new colorectal cancer cases and the number of deaths from colorectal cancer are decreasing a little bit each year. But in adults younger than 50 years, there has been a small increase in the number of new cases each year since 1998. Colorectal cancer is found more often in men than in women. + CancerGov + Colorectal Cancer
Who is at risk for Colorectal Cancer? ?
Different factors increase or decrease the risk of getting colorectal cancer. Anything that increases your chance of getting a disease is called a risk factor. Anything that decreases your chance of getting a disease is called a protective factor.   For information about risk factors and protective factors for colorectal cancer, see the PDQ summary on Colorectal Cancer Prevention. + CancerGov + Colorectal Cancer
What is (are) Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Key Points
                    - Transitional cell cancer of the renal pelvis and ureter is a disease in which malignant (cancer) cells form in the renal pelvis and ureter.    -  Misuse of certain pain medicines can affect the risk of transitional cell cancer of the renal pelvis and ureter.     - Signs and symptoms of transitional cell cancer of the renal pelvis and ureter include blood in the urine and back pain.    - Tests that examine the abdomen and kidneys are used to detect (find) and diagnose transitional cell cancer of the renal pelvis and ureter.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Transitional cell cancer of the renal pelvis and ureter is a disease in which malignant (cancer) cells form in the renal pelvis and ureter.
                    The renal pelvis is the top part of the ureter. The ureter is a long tube that connects the kidney to the bladder. There are two kidneys, one on each side of the backbone, above the waist. The kidneys of an adult are about 5 inches long and 3 inches wide and are shaped like a kidney bean. Tiny tubules in the kidneys filter and clean the blood. They take out waste products and make urine. The urine collects in the middle of each kidney in the renal pelvis. Urine passes from the renal pelvis through the ureter into the bladder. The bladder holds the urine until it passes through the urethra and leaves the body.      The renal pelvis and ureters are lined with transitional cells. These cells can change shape and stretch without breaking apart. Transitional cell cancer starts in these cells. Transitional cell cancer can form in the renal pelvis or the ureter or both.    Renal cell cancer is a more common type of kidney cancer. See the PDQ summary about Renal Cell Cancer Treatment for more information. + CancerGov + Transitional Cell Cancer of the Renal Pelvis and Ureter
What are the symptoms of Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Signs and symptoms of transitional cell cancer of the renal pelvis and ureter include blood in the urine and back pain. These and other signs and symptoms may be caused by transitional cell cancer of the renal pelvis and ureter or by other conditions. There may be no signs or symptoms in the early stages. Signs and symptoms may appear as the tumor grows. Check with your doctor if you have any of the following:         - Blood in the urine.    - A pain in the back that doesn't go away.    - Extreme tiredness.    -  Weight loss with no known reason.     - Painful or frequent urination. + CancerGov + Transitional Cell Cancer of the Renal Pelvis and Ureter
How to diagnose Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Tests that examine the abdomen and kidneys are used to detect (find) and diagnose transitional cell cancer of the renal pelvis and ureter. The following tests and procedures may be used:          -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -   Urinalysis : A test to check the color of urine and its contents, such as sugar, protein, blood, and bacteria.    -   Ureteroscopy : A procedure to look inside the ureter and renal pelvis to check for abnormal areas. A ureteroscope is a thin, tube-like instrument with a light and a lens for viewing. The ureteroscope is inserted through the urethra into the bladder, ureter, and renal pelvis. A tool may be inserted through the ureteroscope to take tissue samples to be checked under a microscope for signs of disease.    -   Urine cytology : A laboratory test in which a sample of urine is checked under a microscope for abnormal cells. Cancer in the kidney, bladder, or ureter may shed cancer cells into the urine.    -   Intravenous pyelogram (IVP): A series of x-rays of the kidneys, ureters, and bladder to check for cancer. A contrast dye is injected into a vein. As the contrast dye moves through the kidneys, ureters, and bladder, x-rays are taken to see if there are any blockages.    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.    -   Ultrasound : A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. An ultrasound of the abdomen may be done to help diagnose cancer of the renal pelvis and ureter.    -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body, such as the pelvis. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   Biopsy : The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. This may be done during a ureteroscopy or surgery. + CancerGov + Transitional Cell Cancer of the Renal Pelvis and Ureter
What is the outlook for Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) depends on the stage and grade of the tumor.   The treatment options depend on the following:         - The stage and grade of the tumor.    -  Where the tumor is.    - Whether the patient's other kidney is healthy.    - Whether the cancer has recurred.        Most transitional cell cancer of the renal pelvis and ureter can be cured if found early. + CancerGov + Transitional Cell Cancer of the Renal Pelvis and Ureter
Who is at risk for Gestational Trophoblastic Disease? ?
Age and a previous molar pregnancy affect the risk of GTD. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk to your doctor if you think you may be at risk. Risk factors for GTD include the following:         - Being pregnant when you are younger than 20 or older than 35 years of age.     - Having a personal history of hydatidiform mole. + CancerGov + Gestational Trophoblastic Disease
What are the symptoms of Gestational Trophoblastic Disease ?
Signs of GTD include abnormal vaginal bleeding and a uterus that is larger than normal. These and other signs and symptoms may be caused by gestational trophoblastic disease or by other conditions. Check with your doctor if you have any of the following:         -  Vaginal bleeding not related to menstruation.    -  A uterus that is larger than expected during pregnancy.    - Pain or pressure in the pelvis.    - Severe nausea and vomiting during pregnancy.    - High blood pressure with headache and swelling of feet and hands early in the pregnancy.    - Vaginal bleeding that continues for longer than normal after delivery.    -  Fatigue, shortness of breath, dizziness, and a fast or irregular heartbeat caused by anemia.        GTD sometimes causes an overactive thyroid. Signs and symptoms of an overactive thyroid include the following:         - Fast or irregular heartbeat.    - Shakiness.    - Sweating.    - Frequent bowel movements.    - Trouble sleeping.    - Feeling anxious or irritable.    - Weight loss. + CancerGov + Gestational Trophoblastic Disease